首页> 外国专利> N-NITROBENZOYLHYDRAZIDE OF MALEIC ACID SHOWING ANTIAGGREGATING ACTIVITY WITH RELATION TO BLOOD PLASMA PLATELATES

N-NITROBENZOYLHYDRAZIDE OF MALEIC ACID SHOWING ANTIAGGREGATING ACTIVITY WITH RELATION TO BLOOD PLASMA PLATELATES

机译:马来酸的N-硝基苯甲酰肼显示出与血血浆板相关的抗凝活性

摘要

FIELD: organic chemistry. SUBSTANCE: new substances showing enhanced activity are synthesized from nitrobenzoic acid hydrazide and maleic anhydride in the medium of acetonitrile. Yield is 91%, m. p. is 179-180 C (for ortho-nitro-derivative) and 96% and m. p. is 195-196 C (for para-nitro-derivative). Synthesized compounds show enhanced activity and less toxicity as compared with that of maleic acid N-benzoylhydrazide. Platelet aggregation degree for synthesized substances is 50%, LD50 = 590-540 mg/kg against 65% and 270 mg/kg at the dose 27 mg/kg. EFFECT: enhanced activity of synthesized compounds. 1 tbl
机译:领域:有机化学。物质:在乙腈介质中,由硝基苯甲酸酰肼和马来酸酐合成具有增强活性的新物质。产率为91%,m。 p。为179-180℃(对于邻硝基衍生物)和96%和m。 p。为195-196℃(对于对硝基衍生物)。与马来酸N-苯甲酰肼相比,合成的化合物显示出增强的活性和更低的毒性。合成物质的血小板凝集度为50%,LD 50 = 590-540 mg / kg,而剂量为27 mg / kg时,其65%和270 mg / kg相对。效果:增强合成化合物的活性。 1汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号